Private Advisor Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-401
Closed -$280K 1780
2020
Q3
$280K Buy
401
+17
+4% +$13.3K ﹤0.01% 1278
2020
Q2
$304K Buy
+384
New +$290K ﹤0.01% 1203
2020
Q1
Sell
-230
Closed -$261K 1446
2019
Q4
$261K Sell
230
-1
-0.4% -$1.09K ﹤0.01% 1339
2019
Q3
$275K Sell
231
-70
-23% -$107K ﹤0.01% 1331
2019
Q2
$496K Buy
301
+3
+1% +$5.19K 0.01% 1048
2019
Q1
$606K Buy
298
+5
+2% +$8.8K 0.01% 895
2018
Q4
$375K Buy
293
+31
+12% +$47.6K 0.01% 938
2018
Q3
$496K Buy
262
+77
+42% +$159K 0.01% 998
2018
Q2
$373K Buy
185
+7
+4% +$16K 0.01% 891
2018
Q1
$393K Sell
178
-10
-5% -$25.4K 0.02% 767
2017
Q4
$415K Sell
188
-22
-10% -$44.7K 0.02% 748
2017
Q3
$358K Buy
210
+15
+8% +$21K 0.01% 1044
2017
Q2
$238K Sell
195
-346
-64% -$418K 0.01% 1186
2017
Q1
$592K Buy
541
+269
+99% +$274K 0.02% 739
2016
Q4
$229K Sell
272
-23
-8% -$18.3K 0.01% 1085
2016
Q3
$265K Buy
+295
New +$214K 0.01% 887
2015
Q3
Sell
-210
Closed -$459K 1047
2015
Q2
$459K Buy
210
+71
+51% +$145K 0.02% 626
2015
Q1
$217K Buy
+139
New +$183K 0.01% 854

Other funds holding BLUE

Private Advisor Group's BLUE Position: Q4 2020 in Review

Private Advisor Group sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 401 shares — an estimated $280K sold.

Private Advisor Group first reported a position in BLUE in Q1 2015 and held it in 18 quarters. The position peaked at $606K in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Private Advisor Group reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Private Advisor Group sold 401 bluebird bio shares in Q4 2020, an estimated $280K.
  • Private Advisor Group first reported a position in bluebird bio in Q1 2015 and held it in 18 quarters.
  • Private Advisor Group's bluebird bio position peaked at $606K in Q1 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Private Advisor Group's 13F filing for Q4 2020, filed 1 Apr 2021.